Clinical Trial Update: Safety and Pharmacokinetics of Ceftolozane/Tazobactam in Pediatric Participants With Nosocomial Pneumonia (MK-7625A-036) [Phase 1]

View source ↗

Summary

Phase 1 safety and pharmacokinetics study of ceftolozane/tazobactam in pediatric participants with hospital-acquired pneumonia (MK-7625A-036) completed; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hospital-acquired Pneumonia

Drugs mentioned

• Ceftolozane/tazobactam (Zerbaxa) (ceftolozane/tazobactam)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Nosocomial Pneumonia | Phase 1 | Status: COMPLETED | Results posted: 2025-09-22